Tuberculosis in migrants - screening, surveillance and ethics.
Ethics
Migrants
Migration
Pre-screening
Review
TB
Tuberculosis
Journal
Pneumonia (Nathan Qld.)
ISSN: 2200-6133
Titre abrégé: Pneumonia (Nathan)
Pays: England
ID NLM: 101663459
Informations de publication
Date de publication:
2020
2020
Historique:
received:
28
06
2020
accepted:
29
07
2020
entrez:
14
9
2020
pubmed:
15
9
2020
medline:
15
9
2020
Statut:
epublish
Résumé
Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a 'silent killer' because it predominantly affects the poor and marginalized, and disease outbreaks occur in 'slow motion' compared to Ebola or coronavirus 2 (COVID-19). In low incidence countries, TB is predominantly an imported disease and TB control in migrants is pivotal for countries to progress towards TB elimination in accordance with the World Health Organisations (WHO's) End TB strategy. This review provides a brief overview of the different screening approaches and surveillance processes that are in place in low TB incidence countries. It also includes a detailed discussion of the ethical issues related to TB screening of migrants in these settings and the different interests that need to be balanced. Given recognition that a holistic approach that recognizes and respects basic human rights is required to end TB, the review considers the complexities that require consideration in low-incidence countries that are aiming for TB elimination.
Identifiants
pubmed: 32923311
doi: 10.1186/s41479-020-00072-5
pii: 72
pmc: PMC7473829
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
9Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
Eur Respir J. 2018 Jul 11;52(1):
pubmed: 29794133
Eur Respir J. 2019 Nov 28;54(5):
pubmed: 31467121
J Clin Tuberc Other Mycobact Dis. 2019 Jan 25;15:100089
pubmed: 31720416
N Engl J Med. 2018 May 31;378(22):2141
pubmed: 29847761
J Epidemiol Community Health. 2006 Apr;60(4):282-4
pubmed: 16537342
BMC Med Ethics. 2018 Mar 2;19(1):16
pubmed: 29499693
PLoS One. 2014 Oct 15;9(10):e108261
pubmed: 25330079
Int J Mycobacteriol. 2016 Dec;5(4):374-378
pubmed: 27931676
Public Health Rep. 2010 Jul-Aug;125 Suppl 4:34-42
pubmed: 20626191
BMC Infect Dis. 2017 Jan 6;17(1):36
pubmed: 28061832
Public Health Rev. 2019 Mar 19;40:3
pubmed: 30923641
Lancet Infect Dis. 2017 Jul;17(7):770-779
pubmed: 28410979
Eur Respir J. 2006 Apr;27(4):801-7
pubmed: 16585088
Psychol Health Med. 2006 Aug;11(3):307-34
pubmed: 17130068
Int J Tuberc Lung Dis. 2014 Feb;18(2):168-73, i-iv
pubmed: 24429308
Lancet Respir Med. 2017 Nov;5(11):846-848
pubmed: 29033268
Front Med (Lausanne). 2019 Jun 21;6:135
pubmed: 31316986
Lancet Infect Dis. 2019 May;19(5):519-528
pubmed: 30910427
Lancet. 2015 Dec 5;386(10010):2344-53
pubmed: 26515679
Eur Respir J. 2018 May 10;51(5):
pubmed: 29748241
BMJ. 2004 Feb 7;328(7435):298-300
pubmed: 14764463
Bioethics. 2004 Nov;18(6):531-52
pubmed: 15580723
Lancet. 2000 Aug 5;356(9228):461-5
pubmed: 10981889
J Infect Dis. 2015 Apr 15;211(8):1306-16
pubmed: 25362193
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637
pubmed: 28482956
Euro Surveill. 2017 Jan 12;22(2):
pubmed: 28106529
PLoS One. 2019 Jul 1;14(7):e0218039
pubmed: 31260481
Eur Respir J. 2015 Nov;46(5):1397-406
pubmed: 26405292
Int J Infect Dis. 2017 Mar;56:90-100
pubmed: 27810521
BMC Infect Dis. 2014 Aug 23;14:455
pubmed: 25149181
Emerg Infect Dis. 2019 Apr;25(4):661-671
pubmed: 30882302
Int J Tuberc Lung Dis. 2010 Oct;14(10):1215-21
pubmed: 20843410
J Med Ethics. 2017 Sep;43(9):632-636
pubmed: 28143943
Global Health. 2017 Mar 15;13(1):15
pubmed: 28298223
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
PLoS One. 2013 Dec 05;8(12):e82440
pubmed: 24349284
Infect Genet Evol. 2016 Jun;40:346-351
pubmed: 26187743
Euro Surveill. 2019 Jan;24(4):
pubmed: 30696526
Euro Surveill. 2018 Apr;23(14):
pubmed: 29637888
Int J Infect Dis. 2017 Mar;56:68-76
pubmed: 27872018
Int J Infect Dis. 2019 Mar;80S:S45-S49
pubmed: 30826482
BMC Med. 2019 Nov 22;17(1):208
pubmed: 31752895
Eur Respir J. 2015 Apr;45(4):928-52
pubmed: 25792630
Lancet Infect Dis. 2013 May;13(5):436-48
pubmed: 23531392
J Public Health (Oxf). 2006 Sep;28(3):253-60
pubmed: 16820434
BMC Med. 2019 Feb 15;17(1):7
pubmed: 30764816
Eur Respir J. 2009 Nov;34(5):1180-9
pubmed: 19880618
Infect Genet Evol. 2020 Jun;80:104169
pubmed: 31918042
Int J Infect Dis. 2017 Mar;56:1-5
pubmed: 28232006
Eur Respir J. 2011 May;37(5):1175-82
pubmed: 21071474
BMC Public Health. 2018 Oct 3;18(1):1151
pubmed: 30285697
Lancet Respir Med. 2020 Jan;8(1):19
pubmed: 31706931
Nat Rev Microbiol. 2019 Sep;17(9):533-545
pubmed: 31209399
Lancet Infect Dis. 2013 Jun;13(6):529-39
pubmed: 23531391
Emerg Infect Dis. 2012 Sep;18(9):1422-9
pubmed: 22931959
ERJ Open Res. 2018 Jul 13;4(3):
pubmed: 30018973
N Engl J Med. 2009 Jun 4;360(23):2406-15
pubmed: 19494216
Int J Environ Res Public Health. 2014 Sep 26;11(10):9954-63
pubmed: 25342234
Epidemiol Infect. 2015 Apr;143(5):887-900
pubmed: 25376279
Lancet Infect Dis. 2017 May;17(5):e128-e143
pubmed: 28291721
Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9051-6
pubmed: 27457933
Health Policy. 2020 Jan;124(1):106-112
pubmed: 31818484
Soc Sci Med. 2009 Jun;68(12):2240-6
pubmed: 19394122
BMC Med. 2016 Mar 23;14:48
pubmed: 27004556
Commun Dis Intell (2018). 2019 Apr 15;43:
pubmed: 30982297
Clin Infect Dis. 2020 May 6;70(10):2111-2118
pubmed: 31246254
Int J Tuberc Lung Dis. 2017 Aug 1;21(8):840-851
pubmed: 28786791
BMC Infect Dis. 2019 Apr 3;19(1):304
pubmed: 30943917
Public Health. 2019 Mar;168:142-147
pubmed: 30771630